Upgrade to SI Premium - Free Trial

Avidity Biosciences Inc. (RNA)

14.19 -0.41 (2.81%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/2/26)
- M&A (3/31/15 *Est)

Latest Headlines

Atrium Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 20, 2026 6:24 PM - PR NewsWire Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18 August 14, 2026 5:47 AM - StreetInsider Atrium Therapeutics Reports Second Quarter 2026 Financial Results August 13, 2026 4:45 PM - PR NewsWire Atrium Therapeutics receives $15M milestone from Bristol Myers Squibb August 13, 2026 8:01 AM - StreetInsider Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration August 13, 2026 8:00 AM - PR NewsWire H.C. Wainwright Starts Atrium Therapeutics (RNA) at Buy August 6, 2026 6:09 AM - StreetInsider Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) July 20, 2026 5:58 PM - PR NewsWire FDA clears Atrium Therapeutics IND for rare heart disease drug July 14, 2026 6:30 AM - StreetInsider Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome July 14, 2026 6:30 AM - PR NewsWire Atrium Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) June 23, 2026 4:05 PM - PR NewsWire Cantor Fitzgerald Starts Atrium Therapeutics (RNA) at Neutral June 18, 2026 6:07 AM - StreetInsider Full Article List